FDA Purple Book: quick access (IBD biologics)
Educational reference only
This page opens the official U.S. FDA Purple Book in a new tab. It does not provide medical advice and does not recommend switching products. The FDA Purple Book is the authoritative source for licensed biological products, including biosimilar and interchangeable listings. Clinical decisions belong with the treating clinician and pharmacist.
The FDA hosts two main ways to search. Simple Search on the homepage is often the fastest way to see products that share a core name (reference, biosimilar, and interchangeable), per the Purple Book FAQs. Advanced Search shows the full data table with filters.
Purple Book homepage (simple search)Advanced SearchDataset downloads
IBD biologics: Purple Book link per agent
Use the suggested search terms on the FDA site (brand and/or nonproprietary name). The FDA site does not support guaranteed pre-filled URLs for a given product.
| Brand name | Nonproprietary name | Suggested search on FDA site | FDA Purple Book |
|---|---|---|---|
| Remicade | infliximab | infliximab or Remicade | Open FDA Purple Book |
| Humira | adalimumab | adalimumab or Humira | Open FDA Purple Book |
| Cimzia | certolizumab pegol | certolizumab pegol or Cimzia | Open FDA Purple Book |
| Simponi | golimumab | golimumab or Simponi | Open FDA Purple Book |
| Entyvio | vedolizumab | vedolizumab or Entyvio | Open FDA Purple Book |
| Stelara | ustekinumab | ustekinumab or Stelara | Open FDA Purple Book |
| Skyrizi | risankizumab-rzaa | risankizumab-rzaa or Skyrizi | Open FDA Purple Book |
| Omvoh | mirikizumab-mrkz | mirikizumab-mrkz or Omvoh | Open FDA Purple Book |
| Tremfya | guselkumab | guselkumab or Tremfya | Open FDA Purple Book |
Regulatory notice
This website is independently developed and is not affiliated with, endorsed by, or sponsored by the FDA. For the current product list, always rely on purplebooksearch.fda.gov.